Personal and Societal Health Quality Lost to Tuberculosis
Open Access
- 8 April 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (4), e5080
- https://doi.org/10.1371/journal.pone.0005080
Abstract
In developed countries, tuberculosis is considered a disease with little loss of Quality-Adjusted Life Years (QALYs). Tuberculosis treatment is predominantly ambulatory and death from tuberculosis is rare. Research has shown that there are chronic pulmonary sequelae in a majority of patients who have completed treatment for pulmonary tuberculosis (PTB). This and other health effects of tuberculosis have not been considered in QALY calculations. Consequently both the burden of tuberculosis on the individual and the value of tuberculosis prevention to society are underestimated. We estimated QALYs lost to pulmonary TB patients from all known sources, and estimated health loss to prevalent TB disease. We calculated values for health during illness and treatment, pulmonary impairment after tuberculosis (PIAT), death rates, years-of-life-lost to death, and normal population health. We then compared the lifetime expected QALYs for a cohort of tuberculosis patients with that expected for comparison populations with latent tuberculosis infection and without tuberculosis infection. Persons with culture-confirmed tuberculosis accrued fewer lifetime QALYs than those without tuberculosis. Acute tuberculosis morbidity cost 0.046 QALYs (4% of total) per individual. Chronic morbidity accounted for an average of 0.96 QALYs (78% of total). Mortality accounted for 0.22 QALYs lost (18% of total). The net benefit to society of averting one case of PTB was about 1.4 QALYs. Tuberculosis, a preventable disease, results in QALYs lost owing to illness, impairment, and death. The majority of QALYs lost from tuberculosis resulted from impairment after microbiologic cure. Successful TB prevention efforts yield more health quality than previously thought and should be given high priority by health policy makers. (Refer to Abstracto S1 for Spanish language abstract)This publication has 30 references indexed in Scilit:
- Using the St. George Respiratory Questionnaire To Ascertain Health Quality in Persons With Treated Pulmonary TuberculosisChest, 2007
- What Are the Costs of Suspected But Not Reported Tuberculosis?Annals of Epidemiology, 2006
- Using Cost and Health Impacts to Prioritize the Targeted Testing of Tuberculosis in the United StatesAnnals of Epidemiology, 2006
- Domestic Returns from Investment in the Control of Tuberculosis in Other CountriesNew England Journal of Medicine, 2005
- Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up studyThorax, 2003
- Tuberculosis-Related Deaths within a Well-Functioning DOTS Control ProgramEmerging Infectious Diseases, 2002
- Lessons from New York's tuberculosis epidemicBMJ, 1998
- Tuberculosis in New York City — Turning the TideNew England Journal of Medicine, 1995
- Five‐Hundred Life‐Saving Interventions and Their Cost‐EffectivenessRisk Analysis, 1995
- Commentary: tuberculosis in New York City--the consequences and lessons of failure.American Journal of Public Health, 1993